Literature DB >> 138491

Quantitation of left ventricular myocardial fiber hypertrophy and interstitial tissue in human hearts with chronically increased volume and pressure overload.

V Fuster, M A Danielson, R A Robb, J C Broadbent, A L Brown, L R Elveback.   

Abstract

Using new techniques, we quantitated left ventricular myocardial fiber hypertrophy and interstitial tissue in four groups of autopsied hearts free of coronary disease: 1) 22 normal hearts, 2) 20 hearts from patients with mitral incompetence (NYHA Class II-III) who died early after mitral valve replacement from causes other than cardiac failure, 3) 22 hearts from patients with mitral incompetence (NYHA Class III-IV) who died early after mitral valve replacement from cardiac failure with low cardiac output syndrome, and 4) 22 hearts from patients with hypertensive heart disease (NYHA Class II-III). Myocardial fiber hypertrophy was quantitated by measuring cross-sectional myocardial fiber diameter; the proportion of interstitial tissue was quantitated by using a computerized, high-resolution video image-digitizing system. Myocardial fiber average diameter in groups 2, 3 and 4 was significantly higher than group 1. The proportion of interstitial tissue was significantly increased in group 3. In chronic mitral incompetence an increase in left ventricular interstitial tissue may play a role in the development of severe cardiac failure.

Entities:  

Mesh:

Year:  1977        PMID: 138491     DOI: 10.1161/01.cir.55.3.504

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  19 in total

1.  Antimyosin antibody imaging in experimental aortic regurgitation.

Authors:  P Lu; P Zanzonico; S M Goldfine; R Hardoff; N Magid; R Gentile; E M Herrold; J S Borer
Journal:  J Nucl Cardiol       Date:  1997 Jan-Feb       Impact factor: 5.952

2.  Differential patterns of replacement and reactive fibrosis in pressure and volume overload are related to the propensity for ischaemia and involve resistin.

Authors:  Elie R Chemaly; Soojeong Kang; Shihong Zhang; LaTronya McCollum; Jiqiu Chen; Ludovic Bénard; K-Raman Purushothaman; Roger J Hajjar; Djamel Lebeche
Journal:  J Physiol       Date:  2013-09-09       Impact factor: 5.182

3.  Left ventricular remodeling in chronic aortic regurgitation.

Authors:  G Barletta; M Di Donato; M Baroni; A Fantini; F Fantini
Journal:  Int J Card Imaging       Date:  1993-09

4.  Myocardial hydroxyproline and mechanical response to prolonged pressure loading followed by unloading in the cat.

Authors:  J F Williams; B Mathew; D L Hern; R D Potter; W P Deiss
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

5.  Relation between regional echo intensity and myocardial connective tissue in chronic left ventricular disease.

Authors:  T R Shaw; R B Logan-Sinclair; C Surin; R J McAnulty; B Heard; G J Laurent; D G Gibson
Journal:  Br Heart J       Date:  1984-01

6.  Imaging technologies for cardiac fiber and heart failure: a review.

Authors:  Shana R Watson; James D Dormer; Baowei Fei
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

7.  Tracer norepinephrine kinetics in coronary circulation of patients with heart failure secondary to chronic pressure and volume overload.

Authors:  C P Rose; J H Burgess; D Cousineau
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

8.  Myocardial capillarity in acclimation to hypoxia.

Authors:  S R Kayar; N Banchero
Journal:  Pflugers Arch       Date:  1985-08       Impact factor: 3.657

9.  Relationship of myocardial morphometry in aortic valve regurgitation to myocardial function and post-operative results.

Authors:  J Perennec; F Herreman; H Cosma; F Ilers; Z Djigouadi; M Degeorges; P Y Hatt
Journal:  Basic Res Cardiol       Date:  1988 Jan-Feb       Impact factor: 17.165

10.  Critical analysis of endomyocardial biopsies from patients suspected of having cardiomyopathy. I: Morphological and morphometric aspects.

Authors:  U Baandrup; E G Olsen
Journal:  Br Heart J       Date:  1981-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.